AGRIN ALS MARKER FÜR ENDOMETRIUMKARZINOM

European patent · EP3655778 · In force

Register entry

Publication number
EP3655778
Application number
EP18749741
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Jul 20, 2018
Published
May 27, 2020
Granted
Jun 7, 2023
Protection ends at the latest
Jul 19, 2038
Next annual fee due
Jul 31, 2027
IPC classes
G01N 33/574 (2006.01)
Priority
EP 17382483 21.07.2017
PCT application
PCT/EP2018/069841 20.07.2018
PCT publication
WO2019/016400 24.01.2019
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Aug 1, 2026

    Next annual fee due on

    Next annual fee due on
    31.07.2026 → 31.07.2027

    Published in Swissreg on 01.08.2026

  2. Aug 1, 2025

    Next annual fee due on

    Next annual fee due on
    31.07.2025 → 31.07.2026

    Published in Swissreg on 01.08.2025

  3. Aug 1, 2024

    Change

    Published in Swissreg on 01.08.2024

  4. Apr 24, 2024

    Change

    Published in Swissreg on 24.04.2024

  5. Apr 17, 2024

    Change

    Published in Swissreg on 17.04.2024

  6. Aug 15, 2023

    Agent entered

    Representative
    BOVARD AG, Patent- und Markenanwälte, Optingenstrasse 16, 3013 Bern

    Published in Swissreg on 15.08.2023

  7. Aug 1, 2023

    Change

    Published in Swissreg on 01.08.2023

  8. Jun 7, 2023

    Granted

    Published in Swissreg on 07.06.2023

Parties

Inventor

COLÁS ORTEGA, Eva

08020 Barcelona, ES

DOMON, Bruno

CH-2534 Orvin

GIL MORENO, Antonio

08172 Sant Cugat Del Vallès, ES

MARTINEZ GARCÍA, Elena

09002 Burgos, ES

LESUR, Antoine

L-8010 Strassen, LU

CAMPOY MONCAYO, Irene

08028 Barcelona, ES

REVENTÓS PUIGJANER, Jaume

08348 Cabrils, ES

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.